Charming Medical Limited Class A Ordinary Shares cash flow to debt ratio of 36.69% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.

Charming Medical Limited Class A Ordinary Shares's free cash flow has increased 63.10% from $84.83K last year to $138.36K, signaling increasing performance

Charming Medical Limited Class A Ordinary Shares's debt to equity ratio is 23.57, which means that the company's assets are unhealthy financed, signaling financial risk.

Charming Medical Limited Class A Ordinary Shares's debt has increased relative to shareholder equity from -0.89 last year to 23.57 today, signaling weakened financials

Charming Medical Limited Class A Ordinary Shares has a net cash position, so leverage is healthy.

Charming Medical Limited Class A Ordinary Shares earns at least as much interest as it pays. Interest obligations are fully covered.

Charming Medical Limited Class A Ordinary Shares's profit margin was 12.93% last year and is 19.27% this year, signaling increasing performance

Charming Medical Limited Class A Ordinary Shares's short-term liabilities of $4.95M exceed its short-term assets of $3.37M, signaling financial risk

Charming Medical Limited Class A Ordinary Shares's return on assets of 22.39% is higher than the 5.00% threshold, indicating efficient asset utilization

Charming Medical Limited Class A Ordinary Shares's return on equity of -232.79%, is lower than 15.00%, indicating bad performance

Charming Medical Limited Class A Ordinary Shares's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Charming Medical Limited Class A Ordinary Shares has insufficient public price history to evaluate earnings stability.

Charming Medical Limited Class A Ordinary Shares has positive free cash flow, indicating the company generates cash after capital expenditures

Charming Medical Limited Class A Ordinary Shares has a free cash flow yield of 0.03%, which is below the 2.00% threshold, indicating limited cash return relative to market value

Charming Medical Limited Class A Ordinary Shares's yearly earnings has increased 54.16% since last year from $777.81K to $1.20M, signaling increasing performance

Charming Medical Limited Class A Ordinary Shares's yearly revenue has increased 3.43% since last year from $6.02M to $6.22M, signaling increasing performance

ROIC 95.92% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.

Charming Medical Limited Class A Ordinary Shares has insufficient revenue history to calculate 3-year revenue CAGR.

Charming Medical Limited Class A Ordinary Shares has insufficient public price history to evaluate revenue consistency.

Charming Medical Limited Class A Ordinary Shares has insufficient public price history to evaluate ROE consistency.

Charming Medical Limited Class A Ordinary Shares has insufficient data to evaluate this check.

Charming Medical Limited Class A Ordinary Shares has an earnings yield of 0.24%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings

Charming Medical Limited Class A Ordinary Shares is overvalued relative to its fair value price of 0.00 based on Base EBITDA Valuation model

Charming Medical Limited Class A Ordinary Shares has an EV/EBITDA ratio of 258.14x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings

Charming Medical Limited Class A Ordinary Shares has insufficient data to evaluate this check.

Charming Medical Limited Class A Ordinary Shares has insufficient diluted EPS history to calculate the PEG ratio.

Charming Medical Limited Class A Ordinary Shares has negative shareholder equity; price-to-book is not meaningful and the check fails

Charming Medical Limited Class A Ordinary Shares has a price-to-sales ratio of 79.91x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue